Waverley Pharma, Inc. (WAVE.V)
0.015
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Waverley Pharma Debt to Equity Ratio : -1.299 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.299 |
| December 31, 2025 | -1.340 |
| September 30, 2025 | -1.365 |
| June 30, 2025 | -1.476 |
| March 31, 2025 | -1.495 |
| December 31, 2024 | -1.509 |
| September 30, 2024 | -1.468 |
| June 30, 2024 | -1.128 |
| March 31, 2024 | -1.226 |
| December 31, 2023 | -1.409 |
| September 30, 2023 | 5.711 |
| June 30, 2023 | 1.685 |
| March 31, 2023 | 0.9996 |
| December 31, 2022 | 0.6065 |
| September 30, 2022 | 0.3277 |
| June 30, 2022 | 0.0225 |
| March 31, 2022 | 0.0389 |
| December 31, 2021 | 0.1243 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kane Biotech, Inc. | -1.352 |
| Quest PharmaTech, Inc. | 0.0378 |
| BriaCell Therapeutics Corp. | 0.00 |
| Vaxil Bio Ltd. | 0.00 |
| Goldcoast Resource Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.195M |
| Total Liabilities (Quarterly) | 3.920M |
| Shareholders Equity (Quarterly) | -2.725M |
| Current Ratio | 0.1081 |
| Net Debt Paydown Yield | -11.68% |